14 July 2016Americas

Illumina to pay Enzo $21m to end patent dispute

Illumina has reached a settlement with Enzo Life Sciences, bringing an end to allegations that it infringed a DNA detection patent.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
7 January 2016   Enzo Biochem has agreed a $9 million settlement with Agilent Technologies in a patent infringement lawsuit centring on technology used in detecting nucleic acid.
Europe
8 September 2017   Genetic sequencing company Illumina has filed a patent infringement suit against Premaitha Health, a molecular diagnostics company, in the English High Court.

More on this story

Americas
7 January 2016   Enzo Biochem has agreed a $9 million settlement with Agilent Technologies in a patent infringement lawsuit centring on technology used in detecting nucleic acid.
Europe
8 September 2017   Genetic sequencing company Illumina has filed a patent infringement suit against Premaitha Health, a molecular diagnostics company, in the English High Court.

More on this story

Americas
7 January 2016   Enzo Biochem has agreed a $9 million settlement with Agilent Technologies in a patent infringement lawsuit centring on technology used in detecting nucleic acid.
Europe
8 September 2017   Genetic sequencing company Illumina has filed a patent infringement suit against Premaitha Health, a molecular diagnostics company, in the English High Court.